Company profile: VIA Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of biotechnology solutions focused on developing small-molecule drugs to treat cardiovascular diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VIA Pharmaceuticals
Atritech
HQ: United States
Website
- Description: Provider of proprietary technology focused on replacing long-term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke, including the WATCHMAN Left Atrial Appendage Closure Technology. Private company founded in 2000 and based in Minneapolis, Minnesota.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atritech company profile →
Tarilian Laser Technologies
HQ: United Kingdom
Website
- Description: Provider of medical technology pioneering an innovative breakthrough in blood pressure monitoring through an unobtrusive wrist-worn wearable device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tarilian Laser Technologies company profile →
XO1
HQ: United Kingdom
Website
- Description: Provider of virtual biotechnology development focused on ichorcumab, operating without offices or laboratories by engaging high-quality contract research and development specialists in Europe and the US, managed by a small team of experienced drug developers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XO1 company profile →
Reva Medical
HQ: United States
Website
- Description: Provider of bioresorbable polymers and medical devices for vascular applications, including MOTIV Bioresorbable Scaffold for below-the-knee peripheral artery disease, Fantom Encore third-generation radiopaque coronary scaffold with thin struts, and TyroSphere bioresorbable embolic microspheres for hypervascular tumors, visible under standard x-ray; all built on the proprietary Tyrocore polymer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reva Medical company profile →
DeVoro Medical
HQ: United States
Website
- Description: Provider of thrombectomy medical devices to restore blood flow, including the WOLF Thrombectomy Platform that captures and removes blood clots from the arterial and venous systems using finger-like prongs, without the need for a console or lytic agents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DeVoro Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VIA Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VIA Pharmaceuticals
2.2 - Growth funds investing in similar companies to VIA Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VIA Pharmaceuticals
4.2 - Public trading comparable groups for VIA Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →